HemoCleanse Inc. other research news

HemoCleanse received a $100,000 Phase I SBIR

Read the full 74 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE